Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Gut Microbes|May 5, 2012
Models for the study of Clostridium difficile infectionEmma L Best, Jane Freeman, Mark H WilcoxJournal of Clinical Microbiology|May 31, 2002
Comparison of pulsed-field gel electrophoresis and amplified fragment length polymorphism techniques for investigating outbreaks of enteritis due to campylobactersOlivia L Champion, Emma L Best, Jennifer A FrostClinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 27, 2010
The potential for airborne dispersal of Clostridium difficile from symptomatic patientsEmma L Best, Warren N Fawley, Peter Parnell, et al.FEMS Microbiology Letters|December 19, 2003
Applicability of a rapid duplex real-time PCR assay for speciation of Campylobacter jejuni and Campylobacter coli directly from culture platesEmma L Best, Ella J Powell, Craig Swift, et al.International Journal of Molecular Sciences|December 23, 2020
Recontamination of Healthcare Surfaces by Repeated Wiping with Biocide-Loaded Wipes: "One Wipe, One Surface, One Direction, Dispose" as Best Practice in the Clinical EnvironmentNicholas W M Edwards, Emma L Best, Parikshit Goswami, et al.Microbial Drug Resistance (Larchmont, N.Y.)|May 13, 2009
Drug-resistant Salmonella Typhimurium DT 120: use of PFGE and MLVA in a putative international outbreak investigationEmma L Best, Michael D Hampton, Steen Ethelberg, et al.Science and Technology of Advanced Materials|May 5, 2017
Role of surface energy and nano-roughness in the removal efficiency of bacterial contamination by nonwoven wipes from frequently touched surfacesNicholas W M Edwards, Emma L Best, Simon D Connell, et al.Antimicrobial Agents and Chemotherapy|November 3, 2020
Optimization of an Assay To Determine Colonization Resistance to Clostridioides difficile in Fecal Samples from Healthy Subjects and Those Treated with AntibioticsHannah C Harris, Emma L Best, Charmaine Normington, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 1, 2020
Efficacy of Bezlotoxumab in Trial Participants Infected With Clostridioides difficile Strain BI Associated With Poor OutcomesStuart Johnson, Diane M Citron, Dale N Gerding, et al.Pageof 1